-
In a large retrospective series, 2051 men with clinically localized prostate cancer received definitive radiation therapy (RT) alone. The rates of aspirin use and statin use were 36% and 34%, respectively. The primary endpoint was IBF (interval to biochemical failure) of < 18 months.
-
A report from the Guttmacher Institute reveals the U.S. teen pregnancy rate is at its lowest level in 40 years and the teen birth rate is at the lowest point since consistent data was collected in the 1950s.
-
A study of cervical cancer incidence and mortality in North Carolina has revealed areas where rates are unusually high, prompting public health officials to call for education, screening, and vaccination programs in impacted areas.
-
According to a new economic analysis of the DC Female Condom program, a public-private partnership to provide and promote FC2 Female Condoms (Female Health Co., Chicago), the program prevented enough HIV infections in the first year alone to save more than $8 million in future medical care costs over and above the cost of the program.
-
Get ready to add two sets of guidance on cervical cancer screening to your practice database: the most current recommendations from the U.S. Preventive Services Task Force (USPSTF) and joint cervical cancer prevention guidelines issued by the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology (ACS/ASCCP/ASCP).
-
How many chlamydia tests were performed on sexually active women ages 15-25 in your clinic last year? If your numbers are similar to a new national analysis, about 38% of sexually active young women ages 15-25 were screened for the sexually transmitted disease (STD).
-
About three million U.S. women experience heavy menstrual bleeding each year.1 With the recent Food and Drug Administration (FDA) approval of Natazia (Bayer HealthCare Pharmaceuticals, Wayne, NJ) for treatment in women who choose an oral contraceptive (OC), clinicians now have another therapeutic option.
-
Long-term follow-up of Lynch syndrome patients who completed 2 years of treatment (aspirin or placebo) on the CAPP2 colorectal cancer prevention trial revealed a significant reduction in colorectal cancer development. This was the first large-scale colon cancer prevention trial using aspirin as an intervention. Implications for the prevention of sporadic colon cancer remain conjectural, however tempting it is to extrapolate these findings to the general adult population.
-
In a prospective trial conducted from 2004-2010, 21 patients (median age 65 years) with a clinical complete response after chemoradiotherapy were followed closely per a stringent wait-and-see policy consisting of MRI, endosopies, and CT scans. These patients were compared to 20 patients prospectively who underwent surgery and were found to have a pathologic complete response.
-